Cullinan Therapeutics, Inc. CGEM Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s total operating expenses?
- Cullinan Therapeutics, Inc. (CGEM) reported total operating expenses of $53.7M in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s total operating expenses changed year-over-year?
- Cullinan Therapeutics, Inc.'s total operating expenses decreased by 2.4% year-over-year, from $55M to $53.7M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Cullinan Therapeutics, Inc.'s total operating expenses has grown at a 29.1% compound annual growth rate (CAGR), from $86.9M to $241.65M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.